Search
ARS Pharmaceuticals Inc
SPRYAdd to Watchlist
9.650USD
-0.250-2.53%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
958.25MMarket Cap
LossP/E TTM
ARS Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of ARS Pharmaceuticals Inc is 6.66, ranking 310 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.82, which is -3841.84% below the recent high of 180.34 and -2306.33% above the recent low of -115.98.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
